$1.6M Grant Funds Research to Stop Smoking-related Lung Disease
Sunday, February 1, 2015
Source: Rochester Business Journal
A University of Rochester Medical Center research team could be on track to develop the first treatment capable of reversing lung damage caused by smoking.
The URMC team has scored a $1.6 million National Institutes of Health grant to fund an expanded study of what members believe could be the first therapy capable of halting or even reversing smoking related lung damage.
Chronic obstructive pulmonary disease, a condition often traceable to smoking, is the third leading cause of death in the United States. Current therapies can relieve COPD symptoms but none can halt or cure the condition.
The team is led by Richard Phipps, director of the lung biology and disease program at the School of Medicine and Dentistry, and Patricia Sime M.D., chief of pulmonary diseases and critical care at Strong Memorial Hospital.